Korean J Pathol.  2003 Dec;37(6):407-412.

Prognostic Significance of P53, BCL-2 and PCNA in Diffuse Large B-Cell Lymphoma: Correlation with International Prognostic Index

Affiliations
  • 1Department of Clinical Pathology, College of Medicine, the Catholic University of Korea, Seoul, Korea. cskang@catholic.ac.kr

Abstract

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) represents a diverse spectrum of clinical presentation, morphology, and genetic and molecular alterations, and shows variable prognoses and responses to therapy. The International Prognosis Index (IPI) is widely used to predict prognosis but is not precise.
METHODS
Thirty-nine cases of DLBCL were classified into low- and high-risk groups according to IPI and were analyzed for their p53, BCL-2, BCL-6 and PCNA expression profile by immunohistochemical staining and overall survival rate.
RESULTS
The mean age of the 39 patients, 23 males and 16 females, was 52.6 years. There were 23 cases (59.0%) in the low-risk group and 16 (41.0%) in the high-risk group. p53, BCL-2, BCL-6 and PCNA expression was higher in the high-risk group than in the low-risk group, but only the differences in p53 and BCL-2 expression were statistically significant (p < 0.05).
CONCLUSION
The p53 and BCL-2 protein expression in DLBCL may supplement IPI in predicting the prognosis of DLBCL patients.

Keyword

Lymphoma, Large Cell, Diffuse; p53; bcl-2; Proliferating Cell Nuclear Antigen

MeSH Terms

B-Lymphocytes*
Female
Humans
Lymphoma, B-Cell*
Lymphoma, Large B-Cell, Diffuse
Male
Prognosis
Proliferating Cell Nuclear Antigen*
Survival Rate
Proliferating Cell Nuclear Antigen
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr